IRulya Therapeutics (IRLA) Total Non-Current Liabilities (2022 - 2026)
IRulya Therapeutics (IRLA) posted Total Non-Current Liabilities of $153.03 million for Q2 2026, up 402.7% from $30.44 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics' Total Non-Current Liabilities came in at $77.28 million, up 186.7% from FY2024.
- Annual Total Non-Current Liabilities shows a three-year compound annual growth rate of 185.6% (FY2022 to FY2025).
- In prior years, IRulya Therapeutics' Total Non-Current Liabilities was $26.96 million in FY2024, -$29.08 million in FY2023 and $3.32 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2022.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $9.76 million (Q1 2026), $77.28 million (Q4 2025) and $32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 96.04 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 153.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.03 Mn |
| Mar 31, 2026 | 9.76 Mn |
| Dec 31, 2025 | 77.28 Mn |
| Sep 30, 2025 | 32.00 Mn |
| Jun 30, 2025 | 30.44 Mn |
| Mar 31, 2025 | -29.44 Mn |
| Dec 31, 2024 | 26.96 Mn |
| Sep 30, 2024 | -28.63 Mn |
| Jun 30, 2024 | -32.69 Mn |
| Mar 31, 2024 | 29.01 Mn |
| Dec 31, 2023 | -29.08 Mn |
| Dec 31, 2022 | 3.32 Mn |
API Access
IRulya Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();